Blueprint Medicines Corporation (NASDAQ: BPMC), a precision therapy company focused on genomically defined cancers, rare diseases and cancer immunotherapy ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Equity Offerings

Blueprint Medicines (BPMC) Prices 4.054M Share Common Offering at $74/ShMarch 29, 2019 5:47 AM Blueprint Medicines Announces Proposed Public Offering of Shares of Common StockMarch 27, 2019 4:03 PM